Borko Jovanovic

  • 7980 Citations
1989 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

I am a Biostatistician, with focus on experimental design and analysis of data in clinical trials, basic science explorations and in epidemiology. Some of my other interests included model selection, prediction models, gene arrays and history of Mathematics and Statistics. I am a member of the Division of Biostatistics and of the Division of Public Health Practice. At Feinberg I taught courses in Clinical Trials, Statistical Consulting and Probability Theory.

My present academic focus is on service to the members of scientific community at Northwestern University, Feinberg School of Medicine and at the H.L. Lurie Comprehensive Cancer Center, and on teaching Probability in the MSEB program. .

Education/Academic qualification

PhD, University of Massachusetts

… → 1991

Research interests

  • Biostatistics
  • Clinical Trial Methodology
  • Colon / Rectal Cancer
  • Drugs (clinical pharmacology)
  • Preventive Medicine
  • Prostate Cancer
  • Public Health
  • Translational Research

Fingerprint Dive into the research topics where Borko Jovanovic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    A phase I trial of berberine in Chinese with ulcerative colitis

    Xu, L., Zhang, Y., Xue, X., Liu, J., Li, Z. S., Yang, G. Y., Song, Y., Pan, Y., Ma, Y., Hu, S., Wen, A., Jia, Y., Rodriguez, L. M., Tull, M. B., Benante, K., Khan, S. A., Cao, Y., Jovanovic, B., Richmond, E., Umar, A. & 2 others, Bergan, R. & Wu, K., Jan 1 2020, In : Cancer Prevention Research. 13, 1, p. 117-126 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Selective progesterone receptor modulators in early-stage breast cancer: A randomized, placebo-controlled phase II window-of-opportunity trial using telapristone acetate

    Lee, O., Sullivan, M. E., Xu, Y., Rogers, C., Muzzio, M., Helenowski, I., Shidfar, A., Zeng, Z., Singhal, H., Jovanovic, B., Hansen, N., Bethke, K. P., Gann, P. H., Gradishar, W., Kim, J. J., Clare, S. E. & Khan, S. A., Jan 1 2020, In : Clinical Cancer Research. 26, 1, p. 25-34 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort

    Carbunaru, S., Nettey, O. S., Gogana, P., Helenowski, I. B., Jovanovic, B., Ruden, M., Hollowell, C. M. P., Sharifi, R., Kittles, R. A., Schaeffer, E., Gann, P. & Murphy, A. B., Nov 27 2019, In : BMC Urology. 19, 1, 121.

    Research output: Contribution to journalArticle

    Open Access
  • Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica

    Burt, R. K., Balabanov, R., Han, X., Burns, C., Gastala, J., Jovanovic, B., Helenowski, I., Jitprapaikulsan, J., Fryer, J. P. & Pittock, S. J., Oct 29 2019, In : Neurology. 93, 18, p. E1732-E1741

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

    Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., Fagius, J., Rose, J., Nelson, F., Barreira, A. A., Carlson, K., Han, X., Moraes, D., Morgan, A., Quigley, K., Yaung, K., Buckley, R., Alldredge, C., Clendenan, A., Calvario, M. A. & 3 others, Henry, J., Jovanovic, B. & Helenowski, I. B., Jan 15 2019, In : JAMA - Journal of the American Medical Association. 321, 2, p. 165-174 10 p.

    Research output: Contribution to journalArticle

  • 36 Scopus citations